These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3408043)

  • 1. [Attack of torsades de pointes induced by an intravenous injection of erythromycin lactobionate].
    Kilani F; Marsepoil T
    Ann Fr Anesth Reanim; 1988; 7(3):270-1. PubMed ID: 3408043
    [No Abstract]   [Full Text] [Related]  

  • 2. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT prolongation and recurrent "torsades de pointes" during erythromycin lactobionate infusion.
    Guelon D; Bedock B; Chartier C; Haberer JP
    Am J Cardiol; 1986 Sep; 58(7):666. PubMed ID: 3751946
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peroperative circulatory arrest after intravenous injection of erythromycin lactobionate].
    Hummel JC; Haberer JP
    Ann Fr Anesth Reanim; 1988; 7(1):85-6. PubMed ID: 3348523
    [No Abstract]   [Full Text] [Related]  

  • 5. [Jet intravenous injection of erythromycin lactobionate. A possible cause of the occurrence of crisis in torsade de pointe].
    Camilleri JF; Deharo JC; Panagidès D; Broin P; Mésana T; Blin D; Mouly-Bandini A; Dubouloz C; Goudard A; Montiès JR
    Ann Cardiol Angeiol (Paris); 1989 Dec; 38(10):657-9. PubMed ID: 2698118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes).
    Schoenenberger RA; Haefeli WE; Weiss P; Ritz RF
    BMJ; 1990 May; 300(6736):1375-6. PubMed ID: 2372583
    [No Abstract]   [Full Text] [Related]  

  • 7. Torsades de pointes induced by erythromycin.
    Gitler B; Berger LS; Buffa SD
    Chest; 1994 Feb; 105(2):368-72. PubMed ID: 8306730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin-induced torsades de pointes and ventricular fibrillation in a patient with Legionella pneumonia.
    de Koning J; van der Hoeven H; Hamer B; Thompson J
    Neth J Med; 1994 Apr; 44(4):131-5. PubMed ID: 8196823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible sensorineural hearing loss with intravenous erythromycin lactobionate.
    Karmody CS; Weinstein L
    Ann Otol Rhinol Laryngol; 1977; 86(1 Pt 1):9-11. PubMed ID: 835977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review.
    Brandriss MW; Richardson WS; Barold SS
    Clin Infect Dis; 1994 Jun; 18(6):995-8. PubMed ID: 8086567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unexpected complication following esophageal variceal hemorrhage - Case 2/2011].
    Werner CR; Riessen R; Gregor M; Bitzer M
    Dtsch Med Wochenschr; 2011 Feb; 136(5):217. PubMed ID: 21271486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrophysiological study of pro-arrhythmogenic effects of erythromycin].
    Ponsonnaille J; Citron B; Richard A; Trolese JF; Chaperon A; Barret B; Gras H
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1001-8. PubMed ID: 3144248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia].
    Lengyel C; Várkonyi T; Fazekas T
    Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants.
    Gouyon JB; Benoit A; Bétremieux P; Sandre D; Sgro C; Bavoux F; Beneton C; Badoual J
    Pediatr Infect Dis J; 1994 Sep; 13(9):840-1. PubMed ID: 7808866
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration.
    Koh TW
    Pacing Clin Electrophysiol; 2001 Oct; 24(10):1575-6. PubMed ID: 11707056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Torsade de pointes induced by the combination lidocaine-erythromycin and hepatic insufficiency].
    Gueugniaud PY; Guerin C; Mahul P; Deu C; Robert D
    Presse Med; 1985 Apr; 14(16):896. PubMed ID: 3158928
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythromycin induced torsades de pointes.
    Wong CB; Windle J
    Nebr Med J; 1995 Sep; 80(9):285-6. PubMed ID: 7566254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous erythromycin lactobionate-induced severe nausea and vomiting.
    Seifert CF; Swaney RJ; Bellanger-McCleery RA
    DICP; 1989 Jan; 23(1):40-4. PubMed ID: 2655295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.